Integrating New Developments in Initial Systemic Treatment in Biliary Tract Cancer Into Clinical Practice: A Spotlight on Immunotherapy

Gain in-depth knowledge on the current and emerging role of immune checkpoint inhibitors in the care of patients with biliary tract cancer, including guideline recommendations and optimal management of immune-related adverse events by attending a local live workshop, downloading the associated slideset, and reviewing an expert-authored commentary on frequently asked questions on this topic.

Share

Program Content

Activities

Immunotherapy for BTC
Integrating New Developments in Initial Systemic Treatment in Biliary Tract Cancer Into Clinical Practice: A Spotlight on Immunotherapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2024

Expires: September 15, 2025

Activities

Immunotherapy for Biliary Tract Cancer
Integrating New Developments in Initial Systemic Treatment in Biliary Tract Cancer Into Clinical Practice: A Spotlight on Immunotherapy
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2024

Expires: April 28, 2025

Activities

FAQs: Immunotherapy in BTC
FAQs: Role of Immunotherapy in Biliary Tract Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2024

Expires: June 17, 2025

Faculty

cover img faculity

Tanios Bekaii-Saab, MD, FACP

David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research I
Chair and Consultant, Division of Hematology and Medical Oncology
Professor
Mayo Clinic College of Medicine and Science
Mayo Clinic in Arizona
Phoenix, Arizona

cover img faculity

Lipika Goyal, MD, MPhil

Associate Professor of Medicine
Director of Gastrointestinal Medical Oncology
Stanford Cancer Center
Palo Alto, California

cover img faculity

Richard Kim, MD

Service Chief of GI Oncology
Professor
Moffitt Cancer Center
Tampa, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca

AstraZeneca